FTXH First Trust Nasdaq Pharmaceuticals ETF

Seeks to track, before fees and expenses, the Nasdaq US Smart Pharmaceuticals Index. The Index selects the 30 most liquid eligible pharmaceuticals securities from the NASDAQ US Benchmark Index and then ranks those securities based on three factors: 1) Volatility trailing 12-month price fluctuation. 2) Value cash flow to price. 3) Growth the 3-, 6-, 9-, and 12-month average price appreciation. The securities are weighted based on their score on the three factors. The index weighting methodology includes caps to prevent high concentrations among single stocks. The index is reconstituted annually and rebalanced quarterly.

$24.29  -0.33 (-1.36%)
As of 09/29/2022 16:00:00 EST     IEX book   CBOE book


ETF Information
Sponsor:     First Trust
Category1:  US Equity
Category2:  Single industry
Category3:  Healthcare
Morningstar category:  Health
Leverage factor:  1.00
Inception date:  09/20/2016
Index tracking method: Passive replication
Current yield:  1.16%
Historical average yield:  1.10%
Market cap:  $36,435,049
Average volume:  23,436
Fees:     0.6000%

Index Information
Nasdaq US Smart Pharmaceuticals Index
Index symbol:  NQSSPH
Provider:   NASDAQ OMX
Total return index symbol:  NQSSPHT
Index weighting:   Composite scores
Index inception date:  07/08/2016
Backtesting data exists:   Yes
Number of holdings:  30
Strategy:  Multi-factor investing
Factors used to select securities:

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy